EP3685826
Sprauta
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
25.1.2013EP published:
3.11.2021EP application number:
20159408.2
EP translation filed:
19.1.2022Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
24.1.2033Expiry date:
24.1.2023
Title in English:
SYRINGELanguage of the patent:
English
Timeline
Today
25.1.2013EP application
3.11.2021EP Publication
19.1.2022Translation submitted
15.2.2022Registration published
24.1.2023Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
SIGG, JuergenAddress:
4002 Basel, CH
Name:
ROYER, ChristopheAddress:
4002 Basel, CH
Name:
BRYANT, Andrew MarkAddress:
4002 Basel, CH
Name:
BUETTGEN, Heinrich MartinAddress:
4002 Basel, CH
Name:
PICCI, MarieAddress:
4002 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
12174860Date:
3.7.2012Country:
EP
Number:
12189649Date:
23.10.2012Country:
EP
Number:
202012011016 UDate:
16.11.2012Country:
DE
Number:
2012101677Date:
16.11.2012Country:
AU
Number:
2012101678Date:
16.11.2012Country:
AU
Number:
202012011260 UDate:
23.11.2012Country:
DE
Number:
202012011259 UDate:
23.11.2012Country:
DE
Number:
12195360Date:
3.12.2012Country:
EP
Number:
202013000688 UDate:
23.1.2013Country:
DE
Number:
2013100071Date:
23.1.2013Country:
AU
Number:
2013100070Date:
23.1.2013Country:
AU
Classification
Categories:
A61K 9/00, A61M 5/28, A61F 9/00, A61M 5/315, A61K 38/17, A61P 27/02, A61P 35/00, A61M 5/31, A61P 9/10
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 19.1.2022
Expires: 24.1.2023
Payer: Árnason Faktor ehf.